Every year, the healthcare industry generates a massive amount of data. In fact, healthcare data currently constitutes around 30% share of the global data volume. Specifically, management and handling of huge datasets in the healthcare industry often requires a large workforce of specialised personnel. Moreover, increasing complexity of healthcare manufacturing operations, along with growing stringency and frequent changes in regulatory requirements has created a dire need for adoption of automated solutions, such as manufacturing execution systems (MES). Out of all the partnerships, technology integration agreement has emerged as the most popular (XX%) type of partnership signed by players engaged in providing manufacturing execution systems.

The Quantum Computing in Drug Discovery Services Market can be characterized by its current position, industry size, anticipated revenue, and the potential market share and volume over the forecast timeframe. An all-inclusive study of the competitive backdrop of the Quantum Computing in Drug Discovery Services Market is a significant element of the latest report. Other significant aspects determining the global market remuneration over the projected timeline:The Quantum Computing in Drug Discovery Services Market report elaborates on the diverse product range, as well as the scope of product application of this particular business vertical. The report draws a precise inference of the Quantum Computing in Drug Discovery Services Market, giving details about the marketing approach of the leading companies, their market positions, and marketing channel development. Get more details on the Quantum Computing in Drug Discovery Services Market report https://www.

The Dental 3D Printing Market is anticipated to grow at a CAGR of 15. The growing burden of dental diseases and the challenges associated with the conventional dental product manufacturing methods has significantly increased the adoption of 3D printing in the dental industry. The popularity of 3D printing technology within the dental industry can be attributed to its ability to print high quality / accurate dental products, including crowns, bridges, dentures, dental implants and surgical guides. Driven by the overall growth of the additive manufacturing (3D printing) industry, and wide adoption of 3D printers in the dental sector, the dental 3D printing market is anticipated to witness a steady growth in the foreseen future. Elaborate profiles of prominent players (shortlisted based on a proprietary criterion) engaged in the dental 3D printing domain.

Every year, the healthcare industry generates a massive amount of data. In fact, healthcare data currently constitutes around 30% share of the global data volume. Specifically, management and handling of huge datasets in the healthcare industry often requires a large workforce of specialised personnel. Moreover, increasing complexity of healthcare manufacturing operations, along with growing stringency and frequent changes in regulatory requirements has created a dire need for adoption of automated solutions, such as manufacturing execution systems (MES). Out of all the partnerships, technology integration agreement has emerged as the most popular (XX%) type of partnership signed by players engaged in providing manufacturing execution systems.

The new market research report titled ‘RNA Therapeutics Market’, published by Roots Analysis offers a comprehensive study of the RNA Therapeutics industry, while estimating the overall market size and the size and share of the key regional segments of the global market over historical period, as well as the projected timeline of 2023–2035. The anticipated market growth is attributed to the significant surge in demand across the regional and global markets for the products and services offered by the RNA Therapeutics industry. The latest study provides readers with a granular analysis of the major developmental elements of the global market, potential business avenues, and the overall market dynamics. Taking into account the existing market development factors, historical events, and recent market trends, the study presents a balanced opinion on the future scenario of the RNA Therapeutics market. Additionally, the report offers many strategic recommendations for companies involved in this ever-growing business sector to help them attain a competitive edge in the RNA Therapeutics market.

Our in-depth analysis of the CAR-T cell therapy market provides valuable insights into current trends, challenges, and opportunities. Mechanisms of CAR-T Cell TherapyTo truly appreciate the potential of CAR-T cell therapy, one must delve into its scientific intricacies. Clinical Triumphs: Success Stories in CAR-T Cell TherapyAmidst the scientific discourse, it's crucial to spotlight the tangible impact of CAR-T cell therapy on patients' lives. Future Horizons: Emerging Trends in CAR-T Cell TherapyThe journey of CAR-T cell therapy is far from over. Get more details on the CAR-T Cell Therapy Market report https://www.

Roots Analysis has the addition of "Digital Health Market: Focus on Digital Therapy (2nd Edition), 2020-2030 (based on solution type (software solution, gaming solution and combined solution), type of therapy (curative and preventive), and purpose of solution (drug replacement and drug augmentation) in your offer list. Alternatively, some digital health products are designed to augment the effects of traditional therapies and are currently being considered to treat substance use disorders and some mental health issues. What is the trend of capital investments in the digital therapeutics market? How is the COVID-19 pandemic likely to impact the digital therapeutics market? What is the trend in capital investments in the digital therapeutics market?

Over the last two decades, the pharmaceutical industry has observed a paradigm shift from conventional drug delivery strategies to the long-acting drug delivery of products to treat several disease indications, such as ophthalmic disorders, oncological disorders, neurological disorders and infectious diseases. In addition, long-acting drug delivery formulations can improve the chemical stability, solubility and polymorphic transformation issues of the active pharmaceutical ingredients. Lately, many technologies are being explored to develop long-acting drugs in various dosage formats, such as long-acting injectables, depot injections, implantable devices and combination products. The long-acting drug delivery technologies have come a long way with the inclusion of liposomes, microspheres and polymers for the fabrication of biodegradable and biocompatible delivery systems. Further, the pharmaceutical industry is extensively focusing on the development of long-acting injectables for protein-based drugs and multidrug therapies.

As a result, 3D bioprinting is nowadays being explored to create intricate anatomical structures in a layer-wise form with the help of computerized technology. The current IP landscape features the presence of over 3,300 patents focused on 3D bioprinting and associated innovations. Additionally, around 40% of the patents were focused on innovations featuring different 3D bioprinted materials, followed by patents focusing on technological advances in 3D bioprinting (17%). Ability to attain exclusivity in futureBased on the white space analysis, the emerging areas of innovation within the 3D bioprinting domain were identified, focusing on different 3D bioprinting systems. Presently, the majority of innovations are observed to be focused on different methods of bioprinting and application of the 3D bioprinting process.

Driven by the ongoing pace of innovation and sufficient financial support from investors, the exosome therapeutics market is anticipated to witness substantial growth in the foreseen future. A detailed analysis of more than 50 completed, ongoing and planned clinical studies of exosome therapeutics. An analysis of start-ups / small companies engaged in the development of exosome therapeutics. An in-depth analysis of exosome therapeutics that failed to progress to later stages of clinical development. How is the current and future market opportunity, related to exosome therapies likely to be distributed across key market segments?

The global auto injector market demand size is hoped to reach US$5. 6% market growth over the forecast period. This is a key factor driving the adoption of auto injectors and is expected to drive the revenue growth of the global market over the forecast period. As per case of income share, North America grows to lead the global market in the present scenario. However, the lack of awareness regarding the use of an auto-injector and the availability of alternative treatment options such as oral tablets are some of the factors that could limit the growth of the auto-injector market during the forecast period.

The liposome development and manufacturing services market is anticipated to grow at a CAGR of nearly 10% till 2035, claims Roots Analysis. In order to deal with the aforementioned challenges, a number of pharmaceutical companies have demonstrated the preference to outsource their respective liposome development and manufacturing operations to specialized service providers. Key Market InsightsMore than 70 companies are currently offering services related to liposome development and manufacturing, globallyMajority (74%) of the service providers offer formulation development services for liposomes. This is followed by players offering analytical method development (65%), liposome contract manufacturing (64%), and process development (61%) services. In order to deal with the aforementioned challenges, a number of pharmaceutical companies have demonstrated the preference to outsource their respective liposome development and manufacturing operations to specialized service providers. The financial opportunity within the liposome development and manufacturing services market has been analyzed across the following segments:Type of Product FormulationTherapeuticNutraceuticalScale of OperationDiscovery / ResearchPreclinicalClinicalCommercialEnd UserPharmaceutical and Biotechnology IndustryCosmetic IndustryFood IndustryAgricultural IndustryAcademicsOther IndustriesKey Geographical RegionsNorth AmericaEuropeAsia-PacificMiddle East and North AfricaLatin AmericaThe Liposome Development and Manufacturing Services Market, 2022–2035 report features the following companies, which we identified to be key players in this domain:Baxter BioPharma SolutionsCharles River LaboratoriesEvonikFresenius KabiFujifilmGEAIntertekAbout Roots AnalysisRoots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry.

Further, the demand for advanced and minimally invasive medical devices has been augmented due to the increase in expenditure on healthcare. Outsourcing Necessity for Medical DevicesNew advancements have facilitated the development and enforcement of more informed regulatory guidelines and instructions to ensure the safety of medical devices. Subtle differences in regulatory guidelines issues across various geographical regions need to be considered by medical device developers in order to receive approval in different markets. Companies involved in Offering Medical Devices Contract Research ServicesCROs tend to actively strive to enhance / upgrade their respective capabilities and expertise to meet the strict quality and safety specifications, as well as to keep up with any change in medical device-related regulations. Growing Number of Mergers and Acquisitions Validate the Interest in this DomainOver the past few years, the merger and acquisitions activity in the medical devices contract research market has increased gradually.

As per the Roots Analysis report, The microbiome manufacturing market has significant growth over the next decade. The human body is known to harbor numerous communities of microbes, including both beneficial and harmful species, which are collectively referred to as the microbiota. Likewise, the ecological system of commensal, symbiotic, and perhaps pathogenic microorganisms that reside within a host system is called the microbiome. In fact, the last two decades have witnessed several developments in the field of microbiome research and their therapeutic applications. However, there are known unmet needs related to manufacturing and research capabilities, quality of products, and time to market, that have restricted growth of this domain to a certain extent.

The Adeno Associated Viral Vector market is anticipated to grow at a CAGR of more than 10% by 2035, claims Roots Analysis. Roots Analysis has announced the addition of “Adeno Associated Viral Vector Market, 2022-2035” report to its list of offerings. The report features an extensive study on the current landscape and the likely future potential of adeno-associated viral vector market over the next decade. It includes a detailed discussion on structure and design, life cycle and applications of adeno-associated viral vectors. The chapter concludes with a discussion on the various advantages and challenges related to adeno-associated viral vectors.

Driven by Kimmtrak® approval, promising development pipeline and encouraging clinical trial results, the TCR-based therapy market is anticipated to witness significant growth in the mid to long-term. An analysis of various types of partnership that have been inked between several stakeholders in the domain of TCR-based therapies. An in-depth analysis of patents related to TCR-based therapies, filed / granted till 2022. A review of the key promotional strategies being adopted by the developers of the approved TCR-based therapies. Close to 60 scientists from renowned universities are presently involved in the clinical development of TCR-based therapies; majority of these KOLs are primarily based in the US and China.